USPTO serial 88693707
Serial No. 88693707
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 22, 2021
- Examiner
- MARTIN, LIEF ANDREW
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 88693707?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $325
Owner
Slayback Pharma Limited Liability Company
Princeton, NJ, US
Other trademarks owned by Slayback Pharma Limited Liability Company
Slayback Pharma Limited Liability Company
Princeton, NJ, US
Other trademarks owned by Slayback Pharma Limited Liability Company
WOBURN, MA, US
Slayback Pharma Limited Liability Company
Princeton, NJ, US
Other trademarks owned by Slayback Pharma Limited Liability Company
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas R. Wolf
Douglas R. Wolf Wolf Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of cardiovascular disorders, allergies, anaphylaxis, central nervous system disorders, peripheral nervous system disorders, reproductive health disorders, electrolytic imbalance, caloric imbalance, obesity, nutritional disorders, autoimmune disorders, endocrine disorders, gastrointestinal disorders, inflammatory disorders, dermatological disorders, infectious diseases, hormonal imbalance, pain, complications arising from organ transplantation, cancer, pulmonary disorders, renal disorders, urinary system disorders, ophthalmic disorders, otic disorders, sense organ disorders, dental disorders, musculoskeletal disorders, diabetic disorders, neuromuscular disorders, bone disorders, blood disorders, metabolic disorders, psychosis; pharmaceutical drugs, preparations and medications for use in sedation, analgesia, anaesthesia; pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of senile disorders, sleep disorders, dementia, congenital disease disorders, abnormal gene disorders, hair growth disorders, gynaecological diseases, obstetric disorders, withdrawal syndromes, hormonal disorders, urogenital organ disorders, sexual dysfunction, nausea and vomiting, emesis, migraine, edema, multiple sclerosis, chronic obstructive pulmonary disorder, depression, pregnancy, spasms, hypertension, hypotension, angioedema, fungal diseases, fertility disorders, hyperglycemia, hypoglycemia, post-operative disorders, arthritis, psoriasis and localized fat deposits; pharmaceutical and biological preparations for use in diagnosis, namely, for use as and X-ray contrast reagents | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Slayback Pharma Limited Liability Company
- Other trademarks owned by Slayback Pharma Limited Liability Company
- Other trademarks owned by AZURITY PHARMACEUTICALS, INC.
- Other trademarks owned by Slayback Pharma Limited Liability Company
- Other trademarks in Class 005
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 19, 2025 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Mar 5, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 16, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 16, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 16, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 16, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 22, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 6, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 6, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 8, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 8, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 9, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 9, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 9, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 18, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 18, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 18, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 22, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 21, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 19, 2019 | NWAP | NEW APPLICATION ENTERED | — |